196 related articles for article (PubMed ID: 23041219)
1. Site specific/targeted delivery of gemcitabine through anisamide anchored chitosan/poly ethylene glycol nanoparticles: an improved understanding of lung cancer therapeutic intervention.
Garg NK; Dwivedi P; Campbell C; Tyagi RK
Eur J Pharm Sci; 2012 Dec; 47(5):1006-14. PubMed ID: 23041219
[TBL] [Abstract][Full Text] [Related]
2. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy.
Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN
Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics.
Wang F; Wang Y; Ma Q; Cao Y; Yu B
Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196
[TBL] [Abstract][Full Text] [Related]
4. Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid.
Pasut G; Canal F; Dalla Via L; Arpicco S; Veronese FM; Schiavon O
J Control Release; 2008 May; 127(3):239-48. PubMed ID: 18346806
[TBL] [Abstract][Full Text] [Related]
5. Role of chitosan nanoparticles in the oral absorption of Gemcitabine.
Derakhshandeh K; Fathi S
Int J Pharm; 2012 Nov; 437(1-2):172-7. PubMed ID: 22909993
[TBL] [Abstract][Full Text] [Related]
6. Temperature-sensitive magnetic drug carriers for concurrent gemcitabine chemohyperthermia.
Kim DH; Guo Y; Zhang Z; Procissi D; Nicolai J; Omary RA; Larson AC
Adv Healthc Mater; 2014 May; 3(5):714-24. PubMed ID: 24574255
[TBL] [Abstract][Full Text] [Related]
7. PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma.
Gaudin A; Song E; King AR; Saucier-Sawyer JK; Bindra R; Desmaële D; Couvreur P; Saltzman WM
Biomaterials; 2016 Oct; 105():136-144. PubMed ID: 27521616
[TBL] [Abstract][Full Text] [Related]
8. Superior preclinical efficacy of gemcitabine developed as chitosan nanoparticulate system.
Arias JL; Reddy LH; Couvreur P
Biomacromolecules; 2011 Jan; 12(1):97-104. PubMed ID: 21117615
[TBL] [Abstract][Full Text] [Related]
9. In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes.
Razzazan A; Atyabi F; Kazemi B; Dinarvand R
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():614-25. PubMed ID: 26952465
[TBL] [Abstract][Full Text] [Related]
10. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
[TBL] [Abstract][Full Text] [Related]
11. Co-delivery of paclitaxel and gemcitabine by methoxy poly(ethylene glycol)-poly(lactide-coglycolide)-polypeptide nanoparticles for effective breast cancer therapy.
Dong S; Guo Y; Duan Y; Li Z; Wang C; Niu L; Wang N; Ma M; Shi Y; Zhang M
Anticancer Drugs; 2018 Aug; 29(7):637-645. PubMed ID: 29846247
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine-loaded innovative nanocarriers vs GEMZAR: biodistribution, pharmacokinetic features and in vivo antitumor activity.
Celia C; Cosco D; Paolino D; Fresta M
Expert Opin Drug Deliv; 2011 Dec; 8(12):1609-29. PubMed ID: 22077480
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
[TBL] [Abstract][Full Text] [Related]
14. Preparation of intravenous injection nanoformulation of VESylated gemcitabine by co-assembly with TPGS and its anti-tumor activity in pancreatic tumor-bearing mice.
Xu Y; Meng H; Du F; Lu W; Liu S; Huang J; Yu J
Int J Pharm; 2015 Nov; 495(2):792-7. PubMed ID: 26410754
[TBL] [Abstract][Full Text] [Related]
15. Magnetic poly epsilon-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model.
Gang J; Park SB; Hyung W; Choi EH; Wen J; Kim HS; Shul YG; Haam S; Song SY
J Drug Target; 2007 Jul; 15(6):445-53. PubMed ID: 17613663
[TBL] [Abstract][Full Text] [Related]
16. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers.
Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E
Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855
[TBL] [Abstract][Full Text] [Related]
17. pH-sensitive stearoyl-PEG-poly(methacryloyl sulfadimethoxine) decorated liposomes for the delivery of gemcitabine to cancer cells.
Bersani S; Vila-Caballer M; Brazzale C; Barattin M; Salmaso S
Eur J Pharm Biopharm; 2014 Nov; 88(3):670-82. PubMed ID: 25157908
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.
Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN
Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934
[TBL] [Abstract][Full Text] [Related]
19. Surface-modified gemcitabine with mucoadhesive polymer for oral delivery.
Lim JH; You SK; Baek JS; Hwang CJ; Na YG; Shin SC; Cho CW
J Microencapsul; 2012; 29(5):487-96. PubMed ID: 22783823
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled drug delivery systems. Part 6: in vitro/in vivo studies of anticancer N-octadecanoyl gemcitabine nanoassemblies.
Jin Y; Lian Y; Du L; Wang S; Su C; Gao C
Int J Pharm; 2012 Jul; 430(1-2):276-81. PubMed ID: 22486963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]